Quon A - Search Results

1

Impact of integrated PET/CT on variability of target volume delineation in rectal cancer.

Patel DA, Chang ST, Goodman KA, Quon A, Thorndyke B, Gambhir SS, McMillan A, Loo BW Jr, Koong AC. Patel DA, et al. Among authors: quon a. Technol Cancer Res Treat. 2007 Feb;6(1):31-6. doi: 10.1177/153303460700600105. Technol Cancer Res Treat. 2007. PMID: 17241098 Free article. Clinical Trial.

2

FDG-PET and beyond: molecular breast cancer imaging.

Quon A, Gambhir SS. Quon A, et al. J Clin Oncol. 2005 Mar 10;23(8):1664-73. doi: 10.1200/JCO.2005.11.024. J Clin Oncol. 2005. PMID: 15755974 Review. No abstract available.

3

Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients.

Fueger BJ, Weber WA, Quon A, Crawford TL, Allen-Auerbach MS, Halpern BS, Ratib O, Phelps ME, Czernin J. Fueger BJ, et al. Among authors: quon a. Mol Imaging Biol. 2005 Sep-Oct;7(5):369-76. doi: 10.1007/s11307-005-0013-4. Mol Imaging Biol. 2005. PMID: 16220355

4

Diagnosis of aseptic deep venous thrombosis of the upper extremity in a cancer patient using fluorine-18 fluorodeoxyglucose positron emission tomography/computerized tomography (FDG PET/CT).

Do B, Mari C, Biswal S, Kalinyak J, Quon A, Gambhir SS. Do B, et al. Among authors: quon a. Ann Nucl Med. 2006 Feb;20(2):151-5. doi: 10.1007/BF02985628. Ann Nucl Med. 2006. PMID: 16615425

5

Merkel cell carcinoma: Is there a role for 2-deoxy-2-[f-18]fluoro-D-glucose-positron emission tomography/computed tomography?

Iagaru A, Quon A, McDougall IR, Gambhir SS. Iagaru A, et al. Among authors: quon a. Mol Imaging Biol. 2006 Jul-Aug;8(4):212-7. doi: 10.1007/s11307-006-0047-2. Mol Imaging Biol. 2006. PMID: 16724293

6

"Flying through" and "flying around" a PET/CT scan: Pilot study and development of 3D integrated 18F-FDG PET/CT for virtual bronchoscopy and colonoscopy.

Quon A, Napel S, Beaulieu CF, Gambhir SS. Quon A, et al. J Nucl Med. 2006 Jul;47(7):1081-7. J Nucl Med. 2006. PMID: 16818940 Free article.

7

F-18 fluorodeoxyglucose PET/CT as an imaging tool for staging and restaging cutaneous angiosarcoma of the scalp.

Vasanawala MS, Wang Y, Quon A, Gambhir SS. Vasanawala MS, et al. Among authors: quon a. Clin Nucl Med. 2006 Sep;31(9):534-7. doi: 10.1097/01.rlu.0000233073.12599.0a. Clin Nucl Med. 2006. PMID: 16921276

8

2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma.

Iagaru A, Quon A, Johnson D, Gambhir SS, McDougall IR. Iagaru A, et al. Among authors: quon a. Mol Imaging Biol. 2007 Jan-Feb;9(1):50-7. doi: 10.1007/s11307-006-0065-0. Mol Imaging Biol. 2007. PMID: 17051322

9

F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas.

Iagaru A, Quon A, McDougall IR, Gambhir SS. Iagaru A, et al. Among authors: quon a. Clin Nucl Med. 2006 Dec;31(12):754-60. doi: 10.1097/01.rlu.0000246846.01492.31. Clin Nucl Med. 2006. PMID: 17117068

10

Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.

Quon A, Fischbein NJ, McDougall IR, Le QT, Loo BW Jr, Pinto H, Kaplan MJ. Quon A, et al. J Nucl Med. 2007 Jan;48 Suppl 1:58S-67S. J Nucl Med. 2007. PMID: 17204721 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters